期刊文献+

喉鳞癌中Galectin-3蛋白的表达及意义 被引量:2

Expression and significance of Galectin-3 protein in laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的检测Galectin-3蛋白在喉鳞癌中的表达,探讨其在喉鳞癌发生发展中的作用。方法应用免疫组织化学法检测62例喉鳞癌组织、50例喉鳞状上皮不典型增生、50例喉鳞状上皮良性增生及42例正常喉鳞状上皮粘膜中Galectin-3的表达差别,并探讨其与临床病理特征的关系。结果 Galectin-3蛋白阳性表达主要定位于细胞浆,Galectin-3蛋白在正常喉粘膜、上皮良性增生、不典型增生及喉鳞癌中的表达阳性率呈增高趋势;Galectin-3蛋白的表达与肿物大小及有无甲状软骨累及密切相关。结论 Galectin-3蛋白在喉鳞癌组织中表达上调,Galectin-3蛋白可能在喉鳞癌癌变过程中起重要作用,术后检测可能对预判断预后有一定价值。 Objective To detect the expression of Galectin-3 protein,and investigate the significance on occurrence and development in laryngeal squamous cell carcinoma.Methods The study included 62 cases of laryngeal squamous cell carcinoma as experimental group,50 cases of atypical hyperplasia,50 cases of benign hyperplasia lesion,42 cases of normal squmous epithelium as control group.We detected the expression of Galectin-3 in different clinical characters by using IHC.Results The expression of Galectin-3 was highest in the laryngeal squmous cell carinoma.The expression of Galectin-3 was correlated with tumor volume and invasion.Conclusion The higher-expression of Galectin-3 is found in laryngeal squamous cell carcinoma.Galectin-3 may promote the occurrence and development in neoplasm.The detection of Galectin-3 should be helpful to predict the prognosis in laryngeal squmous cell carcinoma.
出处 《中国实验诊断学》 北大核心 2011年第9期1485-1487,共3页 Chinese Journal of Laboratory Diagnosis
关键词 喉鳞癌 免疫组织化学 GALECTIN-3 不典型增生 对照 laryngeal squmous cell carcinoma IHC Galectin-3 atypical hyperplasia control observation
  • 相关文献

参考文献8

二级参考文献26

  • 1杨志明,伍晓汀,何涛.Galectin-3与肿瘤转移[J].中国普外基础与临床杂志,2005,12(3):310-313. 被引量:21
  • 2余慧萍,樊祥山,孟凡青,周强,孟奎,张东生.Galectin-3表达与乳腺癌进展、转移关系的研究[J].中国体视学与图像分析,2007,12(2):114-118. 被引量:4
  • 3Matarrese P, Fusco O, Tinari N, et al. Galectin-3 overexpression protects from apoptosis by Improving cell adhesion properties[J].Int J Cancer,2000,85(4) :545-554.
  • 4Weidar N. Intratumor microvessel density as a prognosis factor in cancer[J].Am J Pathol, 1995,147( 1 ) :9-19.
  • 5Wangia-Makker P, Houjo Y, Sarvis R, et al. Galectin-3 induce endothelial cell morphogenesis and angiogenesis [ J ]. Am J Pathol,2000, 156(3) :899-909.
  • 6GREENLEE R T, HILL HARMON M B, MUR- RAY T, et al. Cancer statistics, 2001[J]. CA Canc er J Clin,2001,51:15-36.
  • 7SILVERBERG E, BORING C C, SQUIRES T S. Cancer statisties[J]. CA Cancer J Clin, 1990,40 : 9-- 26.
  • 8SAMBROOK J, FRITSCH E F, MANIATIS T.分子克隆实验指南[M]//金冬雁,黎孟枫,译.第2版.北京:科学出版社,1998:816-856.
  • 9HONJO Y, INOHARA H, AKAHANI S, et al. Ex pression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma[J].Clin Cancer Res, 2000,6:4635--4644.
  • 10SCHOEPPNER H L, RAZ A, HO S B, et al. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon [J]. Cancer, 1995,75:2818--2826.

共引文献6

同被引文献32

  • 1Wang W, I.in P, Han C, et al. Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma. J Exp Clin Cancer Res. 2010, 29 (1):60.
  • 2Blaschuk OW, Devemy E. Cadherins as novel targets for anti cancer therapy. Eur J Pharmacol, 2009, 625(1- 3):195-198.
  • 3Nangia-Makker P, Nakahara S, Hogan V, et al. Galectin-3 in apoptosis, a novel therapeutic target. J Bioenerg Biomembr. 2007, 39(1) :79-84.
  • 4O'Driscoll L, Linehan R, Liang YH, et al. Galectin 3 expression alters adhesion, motility and invasion in a lung cell ling (DI.KP), in vitro. Anticancer Res. 2002, 22(6A) :3117-3125.
  • 5Nelson WJ. Regulation of cell-cell adhesion by the cadherin catenin complex. Biochem Soc Trans, 2008, 36 (Pt2) : 149-155.
  • 6Fujioka T, Takebayashi Y, Kihana T, et al. Expression of E-cadherin and β-catenin in primary and peritoneal metastatic ovarian carcinoma. Oncol Rep, 2001,8 (2): 249-255.
  • 7Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, et al. Association of E-cadherin and β-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas. Hum Pathol. 2004,35 (6) : 663-669.
  • 8Yap AS, Crampton MS Hardin J. Making and breaking contacts: the cellular biology of cadberin regulation. Curr Opin Cell Biol. 2007,19(5):508-514.
  • 9Babal P, Janega P, Cerna A, et al. Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation. Acta Histochem. 2006,108 (2) :133-140.
  • 10Inagaki Y, Tang W, Guo Q, et al. Sialoglycoconjugate expression in primary colorectal cancer and metastatic lymph node tissue. Hepatogastroenterology. 2007,54 (73) :53-57.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部